Facebook Twitter Instagram
    • Home
    • About Journal
      • Aim and Scope
      • Editorial Board
      • Indexing Info
      • Contact Us
    • Browse Issues
      • Articles in Press
      • Current Issue
      • Past Issues
    • For Authors
      • Instructions to Authors
      • Article Processing Charges
      • Submit your article
      • Downloads
    Facebook Twitter Instagram
    Pharmacognosy Communications
    • Home
    • About Journal
      • Aim and Scope
      • Editorial Board
      • Indexing Info
      • Contact Us
    • Browse Issues
      • Articles in Press
      • Current Issue
      • Past Issues
    • For Authors
      • Instructions to Authors
      • Article Processing Charges
      • Submit your article
      • Downloads
    Pharmacognosy Communications
    retyeyutreu
    Original Article

    Semi-Synthetic Pyrazoline Derivatives from Polygonum senegalense Chalcones and their Anti-Microbial Activities

    wadmin2By wadmin2October 6, 2016Updated:August 12, 2021No Comments2 Mins Read
    Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
    Share
    Facebook Twitter LinkedIn WhatsApp Pinterest Email

    Evans Okemwa Kenanda*, Leonidah Kerubo Omosaa
    *Department of Chemistry, School of Pure and Applied Sciences, Kisii University, P.O. Box 408-40200 Kisii, Kenya.
    aDepartment of Chemistry, School of Physical Sciences, University of Nairobi, P.O. Box 30197-00100 Nairobi, Kenya

    Pharmacognosy Communications,2017,7,1,53-60.
    DOI:10.5530/pc.2017.1.8
    Published: October 2016
    Type: Original Article

    ABSTRACT

    This paper describes the semi-synthesis and anti-microbial activity of novel pyrazoline derivatives of Polygonum senegalense chalcones. The study was carried out on the understanding that heterocycles with pyrazoline ring systems are known to possess a broad spectrum of biological activities. The derivatives were afforded by refluxing mixtures of chalcones and phenylhydrazine, hydrazine hydrate, and / or acetic acid in DMSO or ethanol at low temperatures between 40-60°C in an oil-bath. The products were characterized in by 1H-NMR (200 or 400 MHz), 13C-NMR spectroscopy and ESI-HRMS. NMR data was described in detail for each derivative. The compounds 6-15 have been screened for their in vitro anti-bacterial activity against one gram positive bacteria (S. aureus) and anti-fungal activity against five strains C. krusei, C. neoformans, and C. glabrata. They all showed insignificant antimicrobial activities with lower IC50 as compared to positive control, except compound 7 that demonstrated moderate antifungal activity with IC50 values ranging between 8.01 – 13.74 μg/mL against C. krusei, C. neoformans and C. glabrata. The compound also showed antibacterial activity of IC50 value 7.56μg/mL against S. aureus. Based on these findings, we recommend that compound 7 should undergo further structural modification in order to optimize its anti-microbial activity.

    Key words: Aromatic, Exudate, Heterocyclic, Pharmacological.

    Download PDF
    Share. Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
    About Journal
    About Journal

    Pharmacognosy Communications [Phcog Commn.] is a quarterly journal published by Phcog.Net. It is a peer reviewed journal aiming to publish high quality original research articles, methods, techniques and evaluation reports, critical reviews, short communications, commentaries and editorials of all aspects of medicinal plant research. The journal is aimed at a broad readership, publishing articles on all aspects of pharmacognosy, and related fields. The journal aims to increase understanding of pharmacognosy as well as to direct and foster further research through the dissemination of scientific information by the publication of manuscripts. The submission of original contributions in all areas of pharmacognosy are welcome.
    Indexed and Abstracted in : Chemical Abstracts, Excerpta Medica / EMBASE, Google Scholar, CABI Full Text, Ulrich’s International Periodical Directory, ProQuest, Journalseek & Genamics, PhcogBase, EBSCOHost, Academic Search Complete, Open J-Gate, SciACCESS.
    Rapid publication: Average time from submission to first decision is 30 days and from acceptance to In Press online publication is 45 days.
    Open Access Journal: Phcog Commn. is an open access journal, which allows authors to fund their article to be open access from publication.

    © 2025 Pharmacognosy Communications. Maintained by Manuscript TechnoMedia LLP.

    Type above and press Enter to search. Press Esc to cancel.

    Scroll Up